Circulating the HLA-DR+ T Cell Ratio Is a Prognostic Factor for Recurrence of Patients with Hepatocellular Carcinoma after Curative Surgery

BACKGROUND: HLA-DR+ T cell, accounting for 1.2%–5.8% of peripheral lymphocyte, is a type of activated T lymphocyte. This retrospective study aimed to evaluate the prognostic value of HLA-DR+ T cell for progression-free survival (PFS) and overall survival (OS) in hepatocellular carcinoma (HCC) patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Rui-Qian, Sun, Jing-Han, Ma, Yong-Hui, Xie, Yu-Wei, Shao, Guan-Ming, Wang, Cong, Tan, Bin, Liu, Kui, Li, Kun, Li, Na, Hu, Wei-Yu, Cao, Jingyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981292/
https://www.ncbi.nlm.nih.gov/pubmed/36873738
http://dx.doi.org/10.1155/2023/1875153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981292/
https://www.ncbi.nlm.nih.gov/pubmed/36873738
http://dx.doi.org/10.1155/2023/1875153

Ejemplares similares